Condition
Persistent Air Leaks
Total Trials
2
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Endobronchial Blood Patch
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Clinical Trials (2)
Research Network
Common Treatments
- Endobronchial Blood Patch1
- Spiration Valve System Svs Placement1
- Persistent Air Leak Quantification1
Active Sponsors
- Beth Israel Deaconess Medical Center2
- Kai Swenson1
Top Investigators
Beth Israel Deaconess Medical Center